EFFICACY AT THREE YEARS OF DAILY CLINICAL USE OF IGURATIMOD IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
|
作者
Suto, T. [1 ]
Yonemoto, Y. [1 ]
Okamura, K. [1 ]
Tachibana, M. [1 ]
Okura, C. [1 ]
Matsushita, M. [2 ]
Takeuchi, K. [2 ]
Otsuka, K. [2 ]
Ayabe, K. [3 ]
Kaneko, T. [4 ]
Tamura, Y. [4 ]
Inoue, M. [5 ]
Inoue, H. [4 ]
Chikuda, H. [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gunma, Japan
[2] Isesaki Fukushima Hosp, Dept Orthopaed Surg, Isesaki, Japan
[3] Keiyu Hosp, Dept Orthopaed Surg, Tatebayashi, Japan
[4] Inoue Hosp, Dept Orthopaed Surg, Takasaki, Gunma, Japan
[5] Inoue Hosp, Dept Med, Takasaki, Gunma, Japan
关键词
D O I
10.1136/annrheumdis-2017-eular.6040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0439
引用
收藏
页码:1203 / 1204
页数:2
相关论文
共 50 条
  • [1] Efficacy at 52 weeks of daily clinical use of iguratimod in patients with rheumatoid arthritis
    Okamura, Koichi
    Yonemoto, Yukio
    Suto, Takahito
    Okura, Chisa
    Takagishi, Kenji
    MODERN RHEUMATOLOGY, 2015, 25 (04) : 534 - 539
  • [2] The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis
    Suto, Takahito
    Yonemoto, Yukio
    Okamura, Koichi
    Sakane, Hideo
    Takeuchi, Kimihiko
    Tamura, Yasuyuki
    Kaneko, Tetsuya
    Ayabe, Keio
    Chikuda, Hirotaka
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 775 - 781
  • [3] Efficacy of the clinical use of iguratimod therapy in patients with rheumatoid arthritis
    Okamura, Koichi
    Yonemoto, Yukio
    Okura, Chisa
    Kobayashi, Tsutomu
    Takagishi, Kenji
    MODERN RHEUMATOLOGY, 2015, 25 (02) : 235 - 240
  • [4] EFFICACY OF IGURATIMOD FOR RHEUMATOID ARTHRITIS IN ELDERLY PATIENTS
    Mochida, Y.
    Harigane, K.
    Shimazaki, T.
    Inaba, Y.
    Nagaoka, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1470 - 1471
  • [5] EFFICACY OF IGURATIMOD ALONE OR IN COMBINATION WITH METHOTRXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kawamoto, T.
    Umibe, T.
    Iida, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1043 - 1044
  • [6] Genetic predictors of efficacy and toxicity of iguratimod in patients with rheumatoid arthritis
    Xiao, Wenjing
    Guo, Jian-Ping
    Li, Chun
    Ye, Hua
    Wei, Wei
    Zou, Yaohong
    Dai, Lie
    Li, Zhijun
    Zhang, Miaojia
    Li, Xiangpei
    Cai, Xiaoyan
    Zhao, Jianhong
    Wang, Youlian
    Tao, Yi
    Liu, Dongzhou
    Li, Yasong
    Wu, Min
    Sun, Erwei
    Wu, Lijun
    Luo, Li
    Mu, Rong
    Li, Zhanguo
    PHARMACOGENOMICS, 2018, 19 (05) : 383 - 392
  • [7] Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis
    Iwamoto, Naoki
    Tsuji, Sosuke
    Takatani, Ayuko
    Shimizu, Toshimasa
    Fukui, Shoichi
    Umeda, Masataka
    Nishino, Ayako
    Horai, Yoshiro
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Hirai, Yasuko
    Tamai, Mami
    Nakamura, Hideki
    Terada, Kaoru
    Origuchi, Tomoki
    Eguchi, Katsumi
    Ueki, Yukitaka
    Kawakami, Atsushi
    PLOS ONE, 2017, 12 (05):
  • [8] Efficacy and Safety of Iguratimod for Rheumatoid Arthritis.
    Kondo, Tsuneo
    Shibata, Akiko
    Sakai, Ryota
    Chino, Kentaro
    Okuyama, Ayumi
    Takei, Hirofumi
    Amrano, Koichi
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S659 - S659
  • [9] THE EFFICACY AND SAFETY OF IGURATIMOD IN RHEUMATOID ARTHRITIS PATIENTS WITH CHRONIC RENAL FAILURE
    Kume, K.
    Amano, K.
    Yamada, S.
    Kanazawa, T.
    Hatta, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 961 - 961
  • [10] Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
    Li, Jiangtao
    Mao, Hejuan
    Liang, Yan
    Lu, Yanrong
    Chen, Shuo
    Yang, Nanping
    Shi, Guixiu
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,